AGED Diagnostics
PrivateLast Round
Convertible Debt
Sep 6, 2023
Total Funding Raised
$450,000
Company Overview
AGED Diagnostics operates in Healthcare & Life Sciences and is based in Bethesda, Maryland. Its latest recorded funding round was a Convertible Debt round in September 2023.
AGED Diagnostics is a biotechnology company that develops noninvasive blood-based diagnostic tests for liver diseases, including MASH and liver fibrosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AGED Diagnostics Comparables
Compare AGED Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hepta Bio | 94% | |
| CIMA Sciences, LLC | 87% | |
| Glycotest, Inc. | 80% |
For institutional investors. Book with your work email.
AGED Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Sep 6, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AGED Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TEDCO | Convertible Debt |
| Central Texas Angel Network | Seed |
| Intelligence Ventures | Seed |
| Life Science Angels | Seed |
| How Women Invest | Convertible Debt |
| Gloucester Ventures | Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 3, 2024
Grew 300% QoQ from 1 to 4 employees.
- Sep 6, 2023
$450K round led by TEDCO
For institutional investors. Book with your work email.
AGED Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AGED Diagnostics's valuation, stock price, and market status.
Is AGED Diagnostics a public or private company?
AGED Diagnostics is a private company.
What is the current stock price of AGED Diagnostics?
AGED Diagnostics is a private company, so its shares have no public market price. Caplight tracks AGED Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AGED Diagnostics worth (valuation)?
Valuation information for AGED Diagnostics is not publicly available.
Can I buy AGED Diagnostics stock?
AGED Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AGED Diagnostics's last funding round?
AGED Diagnostics's most recent funding round was Convertible Debt on September 6, 2023.
Who are the main investors in AGED Diagnostics?
Key investors in AGED Diagnostics include TEDCO.
Will AGED Diagnostics IPO soon?
No public IPO plans have been announced for AGED Diagnostics.
How can I track AGED Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in AGED Diagnostics's shares on secondary markets.